期刊文献+

不同术式治疗宫颈上皮内瘤变Ⅲ效果比较及随访策略分析 被引量:2

原文传递
导出
摘要 目的 探讨不同术式治疗宫颈上皮内瘤变(CIN)Ⅲ的效果,结合术后液基薄层细胞学检查(TCT)及高危型(HR)-人乳头瘤病毒(HPV)DNA检测预测CINⅢ复发,为手术方式个体化选择提供参考,并探索更为经济有效的随访方案.方法 回顾性分析158例CINⅢ患者分别采用子宫全切术、宫颈冷刀锥切术(CKC)、宫颈环形电锥切术(LEEP)治疗后病变残留及复发情况,评价三种术式的有效性.对术后TCT、HR-HPV DNA检测阳性结果与活检或二次手术病理结果比较,分析TCT、HR-HPV DNA检测预测CINⅢ术后复发的效能.结果 子宫全切术患者复发率为5.26%(4/76),CKC患者为6.25%(2/32),LEEP患者为8.00%(4/50),三者复发率两两比较差异均无统计学意义(P>0.05);CINⅢ术后HR-HPV DNA检测的阴性预测值为100.00%(134/134);术后1~3个月HR-HPV DNA检测结果转阴率最低(52.17%,12/23),与术后4~6个月(80.00%,36/45)、7~9个月(85.57%,83/97)、10~12个月(85.71%,48/56)转阴率比较差异均有统计学意义(P<0.05).结论 CINⅢ患者行子宫全切术不能降低术后复发率;CINⅢ患者术后3个月开始行TCT与HR-HPVDNA联合检测筛查,是性价比较高的随访策略.
出处 《中国医师进修杂志》 2010年第24期53-55,共3页 Chinese Journal of Postgraduates of Medicine
  • 相关文献

参考文献11

  • 1曹泽毅.中华妇产科学[M].2版.北京:人民卫生出版社,2004:305,887.
  • 2Wang KL.Human papillomavirus and vaccination in cervical cancer.Taiwan J Obstet Gynecol,2007,46(4):352-362.
  • 3zur Hausen H.Papillomaviruses in the causation of human cancersa brief historical account.Virology,2009,384(2):260-265.
  • 4Wright TC Jr,Massad LS,Dunton CJ,et al;2006 American Society for Colposcopy and Cervical Pathology-sponsored Consensus Conference.2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ.Am J Obstet Gynecol,2007,197(4):340-345.
  • 5Boulanger JC,Gondry J,Verhoest P,et al.Treatment of CIN after menopause.Eur J Obstet Gynecol Reprod Biol,2001,95 (2):175-180.
  • 6Soutter WP,Sasieni P,Panoskaltsis T.Long-term risk of invasive cervical cancer after treatment of squamous cervical intraepithelial neoplasia.Int J Cancer,2006,118 (8):2048-2055.
  • 7Doyle B,O'Farrell C,Mahoney E,et al.Liquid-based cytology improves productivity in cervical cytology screening.Cytopathology,2006,17 (2):60-64.
  • 8杨怡卓,李亚里,徐滨,付玉荣,李萍.TCT在宫颈病变筛查中的临床价值及不足[J].中国妇产科临床杂志,2008,9(2):87-89. 被引量:39
  • 9Sarian LO,Derchain SF,Andrade LA,et al.HPV DNA test and Pap smear in detection of residual and recurrent disease following loop electrosurgical excision procedure of high-grade cervical intraepithelial neoplasia.Gynecol Oncol,2004,94(1):181-186.
  • 10Dalstein V,Riethmuller D,Pr é tet JL,et al.Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions:a longitudinal French cohort study.Int J Cancer,2003,106(3):396-403.

二级参考文献7

  • 1[2]Doyle B,O'Farrell C,Mahoney E,et al.Liquid-based cytology improves productivity in cervical cytology screening.Cytopathology,2006,17:60-64.
  • 2[4]Andersson S,Safari H,Mints M.Type distribution,viral load and integration status of high-risk human papillomavirus in pre-stages of cervical cancer.Br J Cancer,2005,92:2195-2200.
  • 3[5]Barcelos AC,Adad SJ,Michelin MA,et al.Atypical squamous cells of undetermined significance:analysis of microbiology,cytological criteria and clinical conduct.Turmori,2006,92:213-218.
  • 4[6]Wang N,Emancipator SN,Rose P,et al.Histologic follow-up of atypical endocervical cells.Liquid-based,thin-layer preparation vs.conventional Pap smear.Acta Cytol,2002,46:453-457.
  • 5[7]Gupta D,Kannan V,Komaromy-Hiller G,et al.ASCUS,mature metaplastic type.cytologic diagnosis and follow-up.Acta Cytol,2001,45:192-196.
  • 6潘秦镜,李凌,乔友林,章文华,张询,吴令英,李爱玲,戎寿德,赵芳辉,孙耘田,JeromeL.Belinson,RobertG.Pretorius.液基细胞学筛查宫颈癌的研究[J].中华肿瘤杂志,2001,23(4):309-312. 被引量:443
  • 7郎景和.迎接子宫颈癌预防的全球挑战与机遇[J].中华妇产科杂志,2002,37(3):129-131. 被引量:884

共引文献115

同被引文献17

  • 1Ramchandani SM, Houck KL, Hernandez E, et al. Predictingpersistent/recurrent disease in the cervix after excisional biopsy. MedGenMed, 2007, 9(2 ) : 24.
  • 2Wright TC Jr, Massad LS, Dunton C J, et al. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. J Low Genit Tract Dis, 2007, 11 (4) : 223-239.
  • 3Malapati R, Chaparala S, Cejtin HE. Factors influencing persistence or recurrence of cervical intraepithelial neoplasia after loop electrosurgical excision procedure. J Low Genit Tract Dis, 2011, 15(3) : 177-179.
  • 4Baloglu A, Uysal D, Bezircioglu I, et al. Residual and recurrent disease rates following LEEP treatment in high-grade cervical intraepithelial lesions. Arch Gynecol Obstet, 2010, 282 ( 1 ) :69- 73.
  • 5Jeong NH, Lee NW, Kim H J, et al. High-risk human papillomavirus testing for monitoring patients treated for high-grade cervical intraepithelial neoplasia. J Obstet Gynaecol Res, 2009, 35 (4):706-711.
  • 6Gb'k M, Coup 6 VM, Berkhof J, et al. HPV16 and increased risk of recurrence after treatment for CIN. Gynecol Oncol, 2007,104 ( 2 ) : 273-275.
  • 7Matthews KS, Rocconi RP, Case AS, et al. Diagnostic loop electrosurgical excisional procedure for discrepancy: do preoperative factors predict presence of significant cervical intraepithelial neoplasia? J Low Genit Tract Dis, 2007, 11 (2) : 69-72.
  • 8Nogara FR, Marroni LA, Consolaro ME. Uervlcat cytology oI atypical squamous cells cannot exclude high-grade squamous intraepithelial lesion (ASC-H) : histological results and recurrence after a loop electrosurgical excision procedure. Arch Gynecol Obstet, 2011,284(4) : 965-971.
  • 9Park JY, Lee SM, Yoo CW, et al. Risk factors predicting residual disease in subsequent hysterectomy following conization for cervical intraepithelial neoplasia (CIN) HI and microinvasive cervical cancer. Gynecol Oncol, 2007, 107( 1 ) : 39--44.
  • 10吕美丽.人乳头瘤病毒检测在宫颈病变治疗后随诊中的意义[J].中国基层医药,2009,16(4):672-673. 被引量:13

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部